Intranasal Electrostimulation Device For Dry Eye Symptoms
FDA product code QBR · Class II (moderate risk) · 21 CFR 886.5310 · Ophthalmic
This device type is intended to temporarily increase tear production using neurostimulation to improve dry eye symptoms. For prescription use only.
1510(k) clearances
0PMA approvals
0recalls
Manufacturers
510(k) clearances
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K193589 | TrueTear Intranasal Tear NeurostimulatorQBR · Traditional | Allergan | 08/31/2020SE |